Acro Biomedical CO., LTD. (ACBM) — 10-Q Filings

All 10-Q filings from Acro Biomedical CO., LTD.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

ACBM's Losses Skyrocket Amid Zero Revenue, Going Concern Doubts Mount — Nov 10, 2025 Risk: high
ACRO BIOMEDICAL CO., LTD. (ACBM) reported no revenue for the three and nine months ended September 30, 2025, continuing a trend of no sales since December 31, 2
ACBM Reports Zero Revenue, Continued Losses in Q2 2025 — Aug 5, 2025 Risk: high
ACRO BIOMEDICAL CO., LTD. (ACBM) reported no revenue for the six months ended June 30, 2025, consistent with the prior year period. The company recorded a net l
ACBM Boosts Share Count Amidst Zero Revenue, Q2 2024 — Jul 23, 2025 Risk: high
ACRO BIOMEDICAL CO., LTD. (ACBM) reported no revenue for the six months ended June 30, 2024, consistent with the prior year period. The company's net loss for t
ACBM Posts No Revenue, Eyes Hong Kong for Future Growth — Jul 22, 2025 Risk: high
ACRO BIOMEDICAL CO., LTD. (ACBM) filed its 10-Q for the quarter ended March 31, 2024, indicating no revenue or net income for the period, consistent with its de
ACBM Reports Zero Revenue, Issues 60M Shares for Services — Jul 11, 2025 Risk: high
ACRO BIOMEDICAL CO., LTD. (ACBM) reported no revenue for the nine months ended September 30, 2023, consistent with the prior year, indicating a lack of operatio

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX